Prognosis of Elderly Patients with Gastric Cancer Treated with the Best Supportive Care

Background The prognosis of gastric cancer has gradually improved as treatments have evolved. However, curative treatments might be difficult when gastric cancer is detected in the elderly or individuals with multiple comorbidities. This study investigated the prognosis of elderly patients with gastric cancer who received best supportive care (BSC). Methods This single-center observational study retrospectively reviewed medical records from elderly patients (>65 years-old) diagnosed with gastric cancer between 2014 and 2019 who received BSC. Results Data were obtained from 39 patients with a median age of 90 years. Median follow-up period was 207 days. Median survival time for all causes was 508 days for stage 0, 1026 days for stage I, 319 days for stage II, 317 days for stage III, and 43 days for stage IV. Median survival time for cancer-specific deaths was 1987 days for stage 0, 1280 days for stage I, 331 days for stage II, 371 days for stage III, and 43 days for stage IV. Univariate analyses identified ‘stage’ and performance status as risk factors for both overall and cancer-specific mortality. In multivariate analyses, ‘stage’ was an independent risk factor predicting overall mortality (HR=3.71, 95%CI=1.73–7.98, P < 0.001) and both ‘stage’ and performance status were independent risk factors predicting cancer-specific mortality (HR=4.06 and 8.95, 95%CI=1.13–14.51 and 3.00–26.67, P = 0.031 and P < 0.001, respectively). Conclusion This result will help clarify the natural history of elderly patients with gastric cancer and provide useful information when choosing treatments in the future.